{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T22:54:39Z","timestamp":1791327279809,"version":"4.3.1"},"reference-count":53,"publisher":"eLife Sciences Publications, Ltd","license":[{"start":{"date-parts":[[2023,6,23]],"date-time":"2023-06-23T00:00:00Z","timestamp":1687478400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2023,6,23]],"date-time":"2023-06-23T00:00:00Z","timestamp":1687478400000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2023,6,23]],"date-time":"2023-06-23T00:00:00Z","timestamp":1687478400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["A21135"],"award-info":[{"award-number":["A21135"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010665","name":"European Union Horizon 2020 Marie Sk\u0142odowska-Curie Actions PAVE","doi-asserted-by":"publisher","award":["861190"],"award-info":[{"award-number":["861190"]}],"id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elifesciences.org"],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2023,6,22]]},"abstract":"<jats:p>Pancreatic ductal adenocarcinoma has a poor clinical outcome and responses to immunotherapy are suboptimal. Stromal fibroblasts are a dominant but heterogenous population within the tumor microenvironment and therapeutic targeting of stromal subsets may have therapeutic utility. Here, we combine spatial transcriptomics and scRNA-Seq datasets to define the transcriptome of tumor-proximal and tumor-distal cancer-associated fibroblasts (CAFs) and link this to clinical outcome. Tumor-proximal fibroblasts comprise large populations of myofibroblasts, strongly expressed podoplanin, and were enriched for Wnt ligand signaling. In contrast, inflammatory CAFs were dominant within tumor-distal subsets and expressed complement components and the Wnt-inhibitor SFRP2. Poor clinical outcome was correlated with elevated HIF-1\u03b1 and podoplanin expression whilst expression of inflammatory and complement genes was predictive of extended survival. These findings demonstrate the extreme transcriptional heterogeneity of CAFs and its determination by apposition to tumor. Selective targeting of tumor-proximal subsets, potentially combined with HIF-1\u03b1 inhibition and immune stimulation, may offer a multi-modal therapeutic approach for this disease.<\/jats:p>","DOI":"10.7554\/elife.86125","type":"journal-article","created":{"date-parts":[[2023,6,23]],"date-time":"2023-06-23T14:50:14Z","timestamp":1687531814000},"update-policy":"https:\/\/doi.org\/10.7554\/elife.86125","source":"Crossref","is-referenced-by-count":42,"title":["Spatial determination and prognostic impact of the fibroblast transcriptome in pancreatic ductal adenocarcinoma"],"prefix":"10.7554","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6780-5944","authenticated-orcid":true,"given":"Wayne","family":"Croft","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03angcq70","id-type":"ROR","asserted-by":"publisher"}],"name":"Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham","place":["Birmingham, United Kingdom"]},{"id":[{"id":"https:\/\/ror.org\/03angcq70","id-type":"ROR","asserted-by":"publisher"}],"name":"Centre for Computational Biology, University of Birmingham","place":["Birmingham, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8380-8122","authenticated-orcid":true,"given":"Hayden","family":"Pearce","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03angcq70","id-type":"ROR","asserted-by":"publisher"}],"name":"Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham","place":["Birmingham, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5115-470X","authenticated-orcid":true,"given":"Sandra","family":"Margielewska-Davies","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03angcq70","id-type":"ROR","asserted-by":"publisher"}],"name":"Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham","place":["Birmingham, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1394-3297","authenticated-orcid":true,"given":"Lindsay","family":"Lim","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04tnbqb63","id-type":"ROR","asserted-by":"publisher"}],"name":"Cancer Research Horizons, The Francis Crick Institute","place":["London, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha M","family":"Nicol","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03angcq70","id-type":"ROR","asserted-by":"publisher"}],"name":"Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham","place":["Birmingham, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fouzia","family":"Zayou","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03angcq70","id-type":"ROR","asserted-by":"publisher"}],"name":"Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham","place":["Birmingham, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9501-7451","authenticated-orcid":true,"given":"Daniel","family":"Blakeway","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03angcq70","id-type":"ROR","asserted-by":"publisher"}],"name":"Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham","place":["Birmingham, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7439-8291","authenticated-orcid":true,"given":"Francesca","family":"Marcon","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/048emj907","id-type":"ROR","asserted-by":"publisher"}],"name":"University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital Birmingham","place":["Birmingham, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Powell-Brett","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/048emj907","id-type":"ROR","asserted-by":"publisher"}],"name":"University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital Birmingham","place":["Birmingham, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brinder","family":"Mahon","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/048emj907","id-type":"ROR","asserted-by":"publisher"}],"name":"University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital Birmingham","place":["Birmingham, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reena","family":"Merard","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/048emj907","id-type":"ROR","asserted-by":"publisher"}],"name":"University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital Birmingham","place":["Birmingham, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianmin","family":"Zuo","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03angcq70","id-type":"ROR","asserted-by":"publisher"}],"name":"Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham","place":["Birmingham, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Middleton","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03angcq70","id-type":"ROR","asserted-by":"publisher"}],"name":"Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham","place":["Birmingham, United Kingdom"]},{"id":[{"id":"https:\/\/ror.org\/048emj907","id-type":"ROR","asserted-by":"publisher"}],"name":"University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital Birmingham","place":["Birmingham, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"Roberts","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/048emj907","id-type":"ROR","asserted-by":"publisher"}],"name":"University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital Birmingham","place":["Birmingham, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel M","family":"Brown","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/048emj907","id-type":"ROR","asserted-by":"publisher"}],"name":"University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital Birmingham","place":["Birmingham, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6895-1967","authenticated-orcid":true,"given":"Paul","family":"Moss","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03angcq70","id-type":"ROR","asserted-by":"publisher"}],"name":"Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham","place":["Birmingham, United Kingdom"]},{"id":[{"id":"https:\/\/ror.org\/048emj907","id-type":"ROR","asserted-by":"publisher"}],"name":"University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital Birmingham","place":["Birmingham, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4374","published-online":{"date-parts":[[2023,6,23]]},"reference":[{"key":"bib1","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1051\/medsci\/20143004012","article-title":"Carcinoma-associated fibroblasts in cancer: the great escape","volume":"30","author":"Albrengues","year":"2014","journal-title":"Medecine Sciences"},{"key":"bib2","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1016\/S1470-2045(19)30456-5","article-title":"Progress in cancer survival, mortality, and incidence in seven high-income countries 1995-2014 (ICBP SURVMARK-2): a population-based study","volume":"20","author":"Arnold","year":"2019","journal-title":"The Lancet. Oncology"},{"key":"bib3","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.1158\/0008-5472.CAN-13-2740","article-title":"Cancer-associated fibroblasts expressing CXCL14 rely upon NOS1-derived nitric oxide signaling for their tumor-supporting properties","volume":"74","author":"Augsten","year":"2014","journal-title":"Cancer Research"},{"key":"bib4","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbaa163","article-title":"An approach for normalization and quality control for nanostring RNA expression data","volume":"22","author":"Bhattacharya","year":"2021","journal-title":"Briefings in Bioinformatics"},{"key":"bib5","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1158\/2159-8290.CD-18-0710","article-title":"IL1-induced JAK\/STAT signaling is antagonized by TGF\u03b2 to shape CAF heterogeneity in pancreatic ductal adenocarcinoma","volume":"9","author":"Biffi","year":"2019","journal-title":"Cancer Discovery"},{"key":"bib6","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1152\/physrev.00048.2019","article-title":"Diversity and biology of cancer-associated fibroblasts","volume":"101","author":"Biffi","year":"2021","journal-title":"Physiological Reviews"},{"key":"bib7","doi-asserted-by":"publisher","first-page":"4574","DOI":"10.1158\/1078-0432.CCR-21-1047","article-title":"Neoadjuvant selicrelumab, an agonist Cd40 antibody, induces changes in the tumor microenvironment in patients with resectable pancreatic cancer","volume":"27","author":"Byrne","year":"2021","journal-title":"Clinical Cancer Research"},{"key":"bib8","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1517\/13543784.16.4.467","article-title":"Clinical trials of VEGF receptor tyrosine kinase inhibitors in Pancreatic cancer","volume":"16","author":"Cabebe","year":"2007","journal-title":"Expert Opinion on Investigational Drugs"},{"key":"bib9","doi-asserted-by":"publisher","first-page":"4284","DOI":"10.1200\/JCO.2015.62.8719","article-title":"Randomized phase IB\/II study of gemcitabine plus placebo or vismodegib, a hedgehog pathway inhibitor, in patients with metastatic pancreatic cancer","volume":"33","author":"Catenacci","year":"2015","journal-title":"Journal of Clinical Oncology"},{"key":"bib10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103315","article-title":"Single-cell RNA-seq reveals dynamic change in tumor microenvironment during pancreatic ductal adenocarcinoma malignant progression","volume":"66","author":"Chen","year":"2021","journal-title":"EBioMedicine"},{"key":"bib11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.728062","article-title":"Development and verification of the hypoxia- and immune-associated prognostic signature for pancreatic ductal adenocarcinoma","volume":"12","author":"Chen","year":"2021","journal-title":"Frontiers in Immunology"},{"key":"bib12","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1158\/2159-8290.CD-19-0644","article-title":"Single-cell RNA sequencing reveals stromal evolution into LRRC15(+) myofibroblasts as a determinant of patient response to cancer immunotherapy","volume":"10","author":"Dominguez","year":"2020","journal-title":"Cancer Discovery"},{"key":"bib13","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1158\/2159-8290.CD-19-0094","article-title":"Cross-species single-cell analysis of pancreatic ductal adenocarcinoma reveals antigen-presenting cancer-associated fibroblasts","volume":"9","author":"Elyada","year":"2019","journal-title":"Cancer Discovery"},{"key":"bib14","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1053\/j.gastro.2013.07.025","article-title":"Activated pancreatic stellate cells sequester CD8+ T cells to reduce their infiltration of the juxtatumoral compartment of pancreatic ductal adenocarcinoma","volume":"145","author":"Ene-Obong","year":"2013","journal-title":"Gastroenterology"},{"key":"bib15","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1136\/gutjnl-2011-301220","article-title":"StellaTUM: current consensus and discussion on pancreatic stellate cell research","volume":"61","author":"Erkan","year":"2012","journal-title":"Gut"},{"key":"bib16","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2019.111543","article-title":"Exosomal miRNA-106b from cancer-associated fibroblast promotes gemcitabine resistance in pancreatic cancer","volume":"383","author":"Fang","year":"2019","journal-title":"Experimental Cell Research"},{"key":"bib17","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-015-0844-5","article-title":"MAST: a flexible statistical framework for assessing transcriptional changes and characterizing heterogeneity in single-cell RNA sequencing data","volume":"16","author":"Finak","year":"2015","journal-title":"Genome Biology"},{"key":"bib18","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1053\/j.gastro.2011.06.047","article-title":"Retinoic acid-induced pancreatic stellate cell quiescence reduces paracrine Wnt-\u03b2-catenin signaling to slow tumor progression","volume":"141","author":"Froeling","year":"2011","journal-title":"Gastroenterology"},{"key":"bib19","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2015.1026535","article-title":"HIF-1 is a critical target of pancreatic cancer","volume":"4","author":"Hao","year":"2015","journal-title":"Oncoimmunology"},{"key":"bib20","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1007\/s00595-017-1559-x","article-title":"Expression of podoplanin in stromal fibroblasts plays a pivotal role in the prognosis of patients with pancreatic cancer","volume":"48","author":"Hirayama","year":"2018","journal-title":"Surgery Today"},{"key":"bib21","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.3892\/ijo.2016.3631","article-title":"Cancer-associated fibroblast suppresses killing activity of natural killer cells through downregulation of poliovirus receptor (PVR\/CD155), a ligand of activating NK receptor","volume":"49","author":"Inoue","year":"2016","journal-title":"International Journal of Oncology"},{"key":"bib22","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/nrc1877","article-title":"Fibroblasts in cancer","volume":"6","author":"Kalluri","year":"2006","journal-title":"Nature Reviews. Cancer"},{"key":"bib23","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20210815","article-title":"Lung tumor MHCII immunity depends on in situ antigen presentation by fibroblasts","volume":"219","author":"Kerdidani","year":"2022","journal-title":"The Journal of Experimental Medicine"},{"key":"bib24","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18636-w","article-title":"Phase I clinical trial repurposing all-trans retinoic acid as a stromal targeting agent for pancreatic cancer","volume":"11","author":"Kocher","year":"2020","journal-title":"Nature Communications"},{"key":"bib25","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.ccell.2017.10.005","article-title":"Cancer-associated fibroblasts neutralize the anti-tumor effect of Csf1 receptor blockade by inducing PMN-MDSC infiltration of tumors","volume":"32","author":"Kumar","year":"2017","journal-title":"Cancer Cell"},{"key":"bib26","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1158\/0008-5472.CAN-17-0240","article-title":"Complement activation via a C3A receptor pathway alters Cd4(+) T lymphocytes and mediates lung cancer progression","volume":"78","author":"Kwak","year":"2018","journal-title":"Cancer Research"},{"key":"bib27","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1158\/2159-8290.CD-20-0841","article-title":"Leukocyte heterogeneity in pancreatic ductal adenocarcinoma: Phenotypic and spatial features associated with clinical outcome","volume":"11","author":"Liudahl","year":"2021","journal-title":"Cancer Discovery"},{"key":"bib28","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biology"},{"key":"bib29","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1002\/path.5926","article-title":"Cancer-associated fibroblasts in pancreatic cancer: new subtypes, new markers, new targets","volume":"257","author":"Menezes","year":"2022","journal-title":"The Journal of Pathology"},{"key":"bib30","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1007\/s00441-016-2471-1","article-title":"The roles of tumor- and metastasis-promoting carcinoma-associated fibroblasts in human carcinomas","volume":"365","author":"Mezawa","year":"2016","journal-title":"Cell and Tissue Research"},{"key":"bib31","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/imr.12978","article-title":"Role of cancer-associated fibroblast subpopulations in immune infiltration, as a new means of treatment in cancer","volume":"302","author":"Mhaidly","year":"2021","journal-title":"Immunological Reviews"},{"key":"bib32","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1002\/path.5224","article-title":"Inter- and intra-tumoural heterogeneity in cancer-associated fibroblasts of human pancreatic ductal adenocarcinoma","volume":"248","author":"Neuzillet","year":"2019","journal-title":"The Journal of Pathology"},{"key":"bib33","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1038\/s41590-020-0758-6","article-title":"The NK cell granule protein NKG7 regulates cytotoxic granule exocytosis and inflammation","volume":"21","author":"Ng","year":"2020","journal-title":"Nature Immunology"},{"key":"bib34","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1084\/jem.20162024","article-title":"Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer","volume":"214","author":"\u00d6hlund","year":"2017","journal-title":"The Journal of Experimental Medicine"},{"key":"bib35","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.ccr.2014.04.005","article-title":"Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival","volume":"25","author":"\u00d6zdemir","year":"2014","journal-title":"Cancer Cell"},{"key":"bib36","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1158\/2326-6066.CIR-22-0121","article-title":"Tissue-resident memory T cells in pancreatic ductal adenocarcinoma co-express PD-1 and TIGIT and functional inhibition is reversible by dual antibody blockade","volume":"11","author":"Pearce","year":"2023","journal-title":"Cancer Immunology Research"},{"key":"bib37","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2020.188356","article-title":"Fibrosis and cancer: A strained relationship","volume":"1873","author":"Piersma","year":"2020","journal-title":"Biochimica et Biophysica Acta. Reviews on Cancer"},{"key":"bib38","doi-asserted-by":"publisher","first-page":"11467","DOI":"10.1007\/s13277-014-2459-y","article-title":"Plasma interleukin-11 (IL-11) levels have diagnostic and prognostic roles in patients with pancreatic cancer","volume":"35","author":"Ren","year":"2014","journal-title":"Tumour Biology"},{"key":"bib39","doi-asserted-by":"publisher","DOI":"10.3390\/antib9040057","article-title":"Complement system: promoter or suppressor of cancer progression","volume":"9","author":"Revel","year":"2020","journal-title":"Antibodies"},{"key":"bib40","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1038\/nbt.2931","article-title":"Normalization of RNA-seq data using factor analysis of control genes or samples","volume":"32","author":"Risso","year":"2014","journal-title":"Nature Biotechnology"},{"key":"bib41","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Research"},{"key":"bib42","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/s41586-023-06063-y","article-title":"Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer","volume":"618","author":"Rojas","year":"2023","journal-title":"Nature"},{"key":"bib43","doi-asserted-by":"publisher","DOI":"10.1172\/JCI156774","article-title":"HIF inhibitor 32-134D eradicates murine hepatocellular carcinoma in combination with anti-PD1 therapy","volume":"132","author":"Salman","year":"2022","journal-title":"The Journal of Clinical Investigation"},{"key":"bib44","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1146\/annurev-med-042921-102602","article-title":"Regulation of erythropoiesis by the hypoxia-inducible factor pathway: effects of genetic and pharmacological perturbations","volume":"74","author":"Semenza","year":"2023","journal-title":"Annual Review of Medicine"},{"key":"bib45","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.canlet.2019.03.051","article-title":"CD90 highly expressed population harbors a stemness signature and creates an immunosuppressive niche in pancreatic cancer","volume":"453","author":"Shi","year":"2019","journal-title":"Cancer Letters"},{"key":"bib46","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-12-168","article-title":"Podoplanin expression in cancer-associated fibroblasts enhances tumor progression of invasive ductal carcinoma of the pancreas","volume":"12","author":"Shindo","year":"2013","journal-title":"Molecular Cancer"},{"key":"bib47","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1158\/2326-6066.CIR-21-0539","article-title":"Nkg7 is a T-cell-intrinsic therapeutic target for improving antitumor cytotoxicity and cancer immunotherapy","volume":"10","author":"Wen","year":"2022","journal-title":"Cancer Immunology Research"},{"key":"bib48","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.2353\/ajpath.2010.090899","article-title":"Role of pancreatic stellate cells in pancreatic cancer metastasis","volume":"177","author":"Xu","year":"2010","journal-title":"The American Journal of Pathology"},{"key":"bib49","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.pan.2014.06.008","article-title":"Hypoxia-inducible factor 1\u03b1 expression and its clinical significance in pancreatic cancer: a meta-analysis","volume":"14","author":"Ye","year":"2014","journal-title":"Pancreatology"},{"key":"bib50","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1158\/0008-5472.CAN-13-3009","article-title":"Hypoxia-inducible factor-1 promotes pancreatic ductal adenocarcinoma invasion and metastasis by activating transcription of the actin-bundling protein fascin","volume":"74","author":"Zhao","year":"2014","journal-title":"Cancer Research"},{"key":"bib51","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aat3487","article-title":"Suppression of stromal-derived Dickkopf-3 (DKK3) inhibits tumor progression and prolongs survival in pancreatic ductal adenocarcinoma","volume":"10","author":"Zhou","year":"2018","journal-title":"Science Translational Medicine"},{"key":"bib52","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.790661","article-title":"Prognostic stratification based on HIF-1 signaling for evaluating hypoxic status and immune infiltration in pancreatic ductal adenocarcinomas","volume":"12","author":"Zhuang","year":"2021","journal-title":"Frontiers in Immunology"},{"key":"bib53","doi-asserted-by":"publisher","first-page":"20223","DOI":"10.18632\/oncotarget.7936","article-title":"Adipocytes WNT5a mediated dedifferentiation: a possible target in pancreatic cancer microenvironment","volume":"7","author":"Zoico","year":"2016","journal-title":"Oncotarget"}],"container-title":["eLife"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/cdn.elifesciences.org\/articles\/86125\/elife-86125-v2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/cdn.elifesciences.org\/articles\/86125\/elife-86125-v2.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/elifesciences.org\/articles\/86125","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T21:15:15Z","timestamp":1697058915000},"score":1,"resource":{"primary":{"URL":"https:\/\/elifesciences.org\/articles\/86125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,23]]},"references-count":53,"alternative-id":["10.7554\/eLife.86125"],"URL":"https:\/\/doi.org\/10.7554\/elife.86125","archive":["CLOCKSS"],"relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.01.20.524883","asserted-by":"subject"},{"id-type":"doi","id":"10.1101\/2023.01.20.524883","asserted-by":"object"}],"references":[{"id-type":"accession","id":"GSE210199","asserted-by":"subject"}],"has-review":[{"id-type":"doi","id":"10.7554\/eLife.86125.sa2","asserted-by":"object"},{"id-type":"doi","id":"10.7554\/eLife.86125.sa0","asserted-by":"object"},{"id-type":"doi","id":"10.7554\/eLife.86125.sa1","asserted-by":"object"}]},"ISSN":["2050-084X"],"issn-type":[{"value":"2050-084X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,23]]},"assertion":[{"value":"single anonymised","name":"peer_review_transparency","label":"Peer review transparency","group":{"name":"peer_review_taxonomy"}},{"value":"other reviewer(s), editor","name":"peer_review_interaction","label":"Peer review interaction","group":{"name":"peer_review_taxonomy"}},{"value":"review summaries, review reports, author\/editor communication, reviewer identities reviewer opt in, editor identities","name":"peer_review_published","label":"Peer review published","group":{"name":"peer_review_taxonomy"}},{"value":"open (sign in with ORCID iD required)","name":"post_publication_commenting","label":"Post publication commenting","group":{"name":"post_publication_commenting"}}],"article-number":"e86125"}}